Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted March 11, 2003
Rexall Agrees to Pay up to $12 million to Users of Misleading Cellulite Supplement
On March 11, 2003, the Federal Trade Commission (FTC) reported that Rexall Sundown, Inc. (Rexall) will pay up to $12 million to resolve FTC charges regarding its marketing of the dietary supplement, "Cellasene," a purported cellulite treatment product. The settlement is contingent on approval by the federal district court in Miami and approval of related settlements in class action lawsuits currently pending against Rexall in California and Florida. If approved, the FTC and class action settlements together will provide up to $12 million in redress for consumers throughout the United States who purchased Cellasene.